Florida Cancer Specialists & Research Institute | Strategic Alliance Partners

About Florida Cancer Specialists & Research Institute, LLC: (Homepage)

Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with FCS participation.* Recognized for our research, FCS is a recipient of the national Clinical Trials Participation Award presented by the American Society of Clinical Oncology (ASCO). FCS physicians, trained in prestigious medical schools and research institutes, are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Celebrating its 40th year in 2024, FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies genomic-based treatment and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.

Connect with us:

Latest from Florida Cancer Specialists & Research Institute


Raphael Bosse, MD, PhD Joins Naples-Goodlette

October 13, 2023

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Board-certified hematologist and medical oncologist Raphael Bosse, MD, PhD, has joined the statewide practice.

Tien Do, MD joins FCS Tallahassee Cancer Center

September 06, 2023

Florida Cancer Specialists & Research Institute, LLC is pleased to welcome hematologist and medical oncologist Tien Do, MD to the statewide practice. He is providing care to patients at the FCS Tallahassee Cancer Center, 2351 Phillips Road, Tallahassee, FL.

Precision Medicine at Scale is Here

August 07, 2023

Lucio Gordan, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC, talked with Kevin Keegan, General Manager of Oncology Business with Illumina, about how FCS is bringing precision oncology through analysis of real-world data, innovative technology and research to cancer patients being treated in community settings.

Time to Treatment Matters After a Cancer Diagnosis

July 19, 2023

Finding a comprehensive cancer care provider that is able to provide patients with swift and easy access to the highest-quality diagnosis and treatment planning is essential to reducing stress and ensuring patients achieve the best possible outcomes.